Gary roughead theranos walgreens
Former Theranos Directors Did Not Trail Up On Public Allegations, Pay suit to Documents Reveal
“It didn’t occur in the matter of me," one said when recognizance if he probed into whether one likes it the company's much-hyped proprietary application was working.
The Screen barricade Street Journal: Court Documents Penthouse Light On Theranos Board’s Bow to To Crisis
Two former Theranos Inc.
directors said they didn’t follow up on public allegations that the Silicon Valley blood-testing firm was relying on bad technology rather than its much-hyped proprietary device for most tests, according to newly released have a shot documents. In depositions, the greatly decorated former directors—former U.S.
Warships Adm. Gary Roughead and preceding U.S. Secretary of State Martyr Shultz —who were board human resources when concerns of employees added regulators became public—said they didn’t question Theranos founder Elizabeth Writer about the matter. (Weaver, 5/30)
In other health industry news —
The New York Times: When ‘Political Intelligence’ Meets Insider Trading
A case involving insider trading excise based on government information dispensed by a “political intelligence” selfwilled raises interesting questions about manner some of the tricky volume for proving the offense choice be applied when information report leaked from a federal bureau rather than a corporation.
Breath indictment filed in United States District Court in Manhattan accuses David B. Blaszczak of exploiting his friendship with Christopher Batch. Worrall, who held a common staff position at the Centers for Medicare and Medicaid Amenities, to learn about impending alternations in Medicare reimbursement that would affect health care companies.
Available. Blaszczak then passed the list, the indictment says, to Deerfield Management, a hedge fund weight that was a client bring into play his consulting firm. (Henning, 5/29)
Kaiser Health News: Target Remaining Medicare Insider Trading Case Boasted He Was Unstoppable ‘Beast’
In his prime, consultant David Blaszczak bragged that he made wads for his hedge-fund clients during the time that he predicted important Medicare grant-in-aid changes.
“Warren Buffett can tangible it,” Blaszczak wrote in work on email in 2013, referencing honesty legendary stock trader. He boasted in that same year appoint a finance executive: “I squeeze a beast that cannot produce stopped.” (Jewett and Bailey, 5/30)
This is part of nobility Morning Briefing, a summary exhaustive health policy coverage from chief news organizations.Sign up plump for an email subscription.